shr-1209
Showing 1 - 4 of 4
Hyperlipidemia Trial in Guangzhou (SHR-1209, Placebo)
Completed
- Hyperlipidemia
- SHR-1209
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital ,The Second Affiliated Hospital of
Nov 29, 2022
Hypercholesterolemia and Hyperlipidemia Trial (SHR-1209)
Completed
- Hypercholesterolemia and Hyperlipidemia
- SHR-1209
-
Hefei, Anhui, ChinaThe Second Affiliated Hospital of Anhui Medical University
Jan 10, 2023
Primary Hypercholesterolemia, Mixed Hyperlipemia Trial in Guangzhou (SHR-1209, SHR-1209 Placebo)
Active, not recruiting
- Primary Hypercholesterolemia
- Mixed Hyperlipemia
- SHR-1209
- SHR-1209 Placebo
-
Guangzhou, Guangzhou, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 9, 2022
Primary Hypercholesterolemia Trial in Guangzhou (SHR-1209, SHR-1209 Placebo)
Active, not recruiting
- Primary Hypercholesterolemia
- SHR-1209
- SHR-1209 Placebo
-
Guangzhou, Guangzhou, ChinaGuangdong Provincial People's Hospital
May 15, 2022